The 3Ps for Scaling AI in Pharma: Pilots, Procurement, and Partnerships

Scaling AI in the pharmaceutical industry requires more than advanced models or isolated innovation efforts. It demands the right enterprise foundations, governance, and decision-making structures to support responsible adoption.

In this vodcast, Vikas Mahajan is joined by Siddharth Saluja to explore how procurement plays a critical role in enabling enterprise AI strategy in pharma. The discussion sheds light on how procurement has evolved from a traditional cost and control function into a strategic enabler of AI scaling across the organization.

The conversation focuses on how procurement supports AI adoption through governance, data privacy, compliance, contractual frameworks, and third-party risk management, creating the guardrails required for sustainable innovation. It also examines how procurement collaborates with digital teams, risk and compliance, business stakeholders, and partners to balance speed with responsibility.

Ultimately, the discussion makes clear that procurement is a critical enabler of enterprise AI strategy, turning intent into execution as organizations scale AI in pharma.